Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Since you bought at 2.40, are you still reporting the short sales data later on? LOL
Really, I've never said 10 for 1... 4 for 1 would do the trick. So what's the alternative, let the PPS float which is down 45 percent YTD? The PPS has not gone up on so-called great news... The only other option is a partnership, and Leo seemed hesitant when asked about this last year. There's no interest in CTIX when trading on the pinks, getting up-listed should be the main focus. If not, then Leo should be calling "all possible" partner candidates.
Leo has lost total control of the stock. The pink sheet market has an iron fist on the PPS direction. There's nothing Leo can do except try to up-list. He had an opportunity earlier in the year, but wasn't prepared with BOD's and so on... Then, he could have up-listed with a RS, but instead chose to let the stock price float. Well, 3 PR's later and we see exactly how that's going... Up to 3.60 last week, now back to 2.37 on life support... And Leo expects new investors to buy shares? Time to change strategy... Partnership or RS ASAP...
Getting closer to 2... You might be correct, while Leo's the goat...
Let's examine Leo's Up-listing PR from June 8th...
To me "near term" developments have to be the last 3 PR's included since it's now 2 months since... Just my opinion...
http://finance.yahoo.com/news/cellceutix-provides-uplist-application-115823200.html
Cellceutix wishes to reiterate its stance that it will not perform a reverse split to meet the higher share price requirement. The Company is of the opinion that a number of near-term pipeline developments will remedy any concern with an uplist on the merits of the continued strong fundamentals of Cellceutix.
Expected developments in the coming weeks and months include the conclusion of the Phase 1 trial of Kevetrin for solid tumors and initiation of mid-stage trials of Kevetrin for solid and liquid tumors; the ongoing Phase 2 trial of Brilacidin-OM for oral mucositis; and the start of the Phase 2 trial of Prurisol for psoriasis. Additionally, Cellceutix is meeting with the U.S. Food and Drug Administration in the upcoming weeks to discuss initiating a Phase 3 trial of Brilacidin for Acute Bacterial Skin and Skin Structure Infections.
What a difference 2 weeks make. Leo's assumption on a higher price "with news" is getting slammed back in-his-face. If the selling continues, he'll be forced to do a RS or get a partnership deal. Yesterday's PR was a waste of time... When manipulators have more control than the CEO, it's time for a new strategy.
Guess the manipulators are done selling? Maybe, the start of a rebound?
Really, so a partnership is not a viable solution than being swallowed alive by the pink-sheets? OK, hopefully Leo's next PR will do the trick...
News this year hasn't done a thing to the PPS. In fact, the PPS is down 40 percent YTD. Again, I'm not happy to do a RS, but hopefully the past few weeks has swayed Leo's strategy to form a partnership. Leo said, he's hopeful the PPS would rise with news... This was before K and B news... If he doesn't want a RS and news doesn't drive the PPS higher, then the only alternative is to license out B... Going to be hard raising enough funds on a corrupt pink-sheet market. Also, if new investors aren't attractive to the stock, then the alternative could be bankruptcy or sell off the scraps like Polymedix did. Using the pink sheets as your line-of-credit is dangerous.
The Kevetrin PR from July 15th, Leo said an update SOON!!! My guess is he's waiting for the Prurisol trial to start, which was pending late July...
We wanted to inform shareholders immediately of this important news and will be updating shareholders shortly on all clinical developments.” - See more at: http://cellceutix.com/cellceutixs-kevetrin-receives-fda-orphan-drug-designation-for-the-treatment-of-ovarian-cancer/#sthash.Or0cBNYq.dpuf
Irrational behavior would be to panic sell and let the manipulators/shorts win. GLTY
Yes Romad Diver, it is the market. The pink sheet market... I think everyone here understands the risk. Not many expected the 360 in price. Except, the manipulators who exploited the stock for their gains. Which is why the up-listing debate heats up... GLTY
frrol, this is an opinionated forum. What facts can you provide that explain a (360 reversal) on 2 promising news events? Was it the hot weather in the east?
Leo has no control over the PPS. The manipulators on the pinks control CTIX.
The 1-month chart says it all...
http://finance.yahoo.com/echarts?s=CTIX+Interactive#{%22range%22:%221mo%22,%22allowChartStacking%22:true}
It's real simple, Leo botched the up-listing when he believed the PPS would rise and be sustained on news. Well, it did rise, but like always retreats back. Aruda and flippers make money here. The big investors don't invest on the pinks....
What rising PPS? Not this year so far... A 3 month stretch in 2014 and that's been it for the past 2 years. Leo's inability to up-list and the Aruda settlement have thrown a dark cloud on this investment.
Live and die by the sword... Sword in this case are the pink sheets... Leo's assumption "on a rising PPS" being sustained has been proven incorrect. Zero exposure on the pinks.
The closing price 7/15 was 2.64 before the K news. Reached a high of 3.65 on 7/20... Now, currently below the initial rally (2.60). Unless they form a partnership, or get off the pinks, this will be a continued cycle.
http://finance.yahoo.com/q/hp?s=CTIX+Historical+Prices
Wasn't anything great about this week. Maybe Sunday, Leo will go to church and pray for a reversal?
LR, TNX for the correction. CTIX has some control which is good. This was a big discussion a few years back (Aspire). One poster seemed to waken the dead.
Regardless of who's doing what, most everyone here is in agreement that CTIX needs to up-list ASAP. Some suggest a RS, while others believe the PPS will rise enough to qualify. Leo is calling the shots, but he will have to rethink his game-plan after watching a complete 360 reversal after 2 important press-releases... As always, time-will-tell...
luxe, Aspire selling shares would cause the out-share total to increase big-time. 115,838,129 outstanding as of December 31, 2014, the March 31, filing listed 117 million... We will see June 30th figures in the next Q report in August. My opinion it's Aruda selling with MM's manipulating up and down.
Don't you have the option to use All or none trades for limit orders? This limits multiple blocks and prevents the MM's from manipulating. It may take longer to fill, but volume is decent enough to eventually do so...
Maybe, Aruda's "million share" market sell-order has filled? Some seller "with many shares" has manipulated the price since last week. Wouldn't be surprised if it was Aruda's army... Hopefully, the rebound starts today?
Leo said an update shortly from the K PR. I assume, it would be when P starts, then Leo can group everything to one update. Just my guess.
We wanted to inform shareholders immediately of this important news and will be updating shareholders shortly on all clinical developments.” - See more at: http://cellceutix.com/cellceutixs-kevetrin-receives-fda-orphan-drug-designation-for-the-treatment-of-ovarian-cancer/#sthash.6q350aEO.dpuf
Good post, corporate update 22 will reveal the same gossip that's been known and posted here. We start the P trial, old news... A recap of Leo's last 4 press releases, followed by how great the prospects are. But the biggest blunder of 2015 missing, Leo's inability to up-list in time... Not having BOD's in place last-year cost him an up-listing. Now, Leo is trapped on the pinks without a RS...
TOB, That's your opinion, the PPS tells a different tale. YTD, Down 40 percent on how many press releases? Down 40 percent with the Merck/Cubist deal. Again, logic suggests the reason behind the decline has to be the market they trade on? Leo is gambling the PPS can outweigh the manipulation... So far, he's lost time and possibly a partnership. I don't know any pink-sheet biotechs who have been partnered? Too risky for the large players.
PPS almost back to pre K/B news last week. 2.64 up to 3.60 back down to 2.75... All in less than 2 weeks. What a way promote your stock/business...
Yep, A RS and we'd be on the Nasdaq... Leo is trying to qualify with price appreciation. So far, he's losing that battle. Only partnership news will move this forward.
That's for me to know and you to find out... I'm a shareholder like yourself, but I don't give Leo as much credit as you do. He might have rescued the company, but he's being paid back a handsome salary and loan repayment. Menon is the key to the company... As long as he's here, I'll stay invested.
Lets revisit Leo's last PR on up-listing from June 8th... B and K news out since then, can be concluded as near-term...
Cellceutix wishes to reiterate its stance that it will not perform a reverse split to meet the higher share price requirement. The Company is of the opinion that a number of near-term pipeline developments will remedy any concern with an uplist on the merits of the continued strong fundamentals of Cellceutix. - See more at: http://cellceutix.com/cellceutix-provides-update-on-uplist-application/#sthash.R5misWFn.dpuf
The market CTIX trades on is relevant to the science. CTIX raises funds to keep the company afloat. There's been small biotech companies who have had science, but lost everything. Prime example Polymedix, which is how CTIX got B. I wouldn't be so confident "in saying" it doesn't matter what market they trade on? CTIX has funding for the current phase trials, but will need way more cash next year and so on... A PPS being manipulated is currently CTIX's credit line.
It wouldn't make sense for Aspire to short. Why would they danger the hands that feed them? They make money on discounted shares. Again, the dilution numbers don't point to Aspire selling much. The main cause of PPS failure "my opinion" is not-uplisting and Aruda.
Nice article on the Pink Sheet Market. This is why Leo needs to move off ASAP... There's no exposure for companies on the pinks.
http://www.investopedia.com/ask/answers/201.asp
The Pink Sheets are different from the OTCBB. Companies on the Pink Sheets are not required to meet minimum requirements or file with the SEC. So-named because they were actually printed on pink paper, the Pink Sheets started out as a daily quote service provided by the National Quotation Bureau. Typically, companies are on the Pink Sheets because either they are too small to be listed on a national exchange or they do not wish to make their budgets and accounting statements public. To avoid having to file with the SEC, some large foreign companies such as Nestle S.A. have penetrated the American securities markets through the Pink Sheets. Companies listed on the Pink Sheets are difficult to analyze because it is tough to obtain accurate information about them. The companies on the Pink Sheets are usually penny stocks and are often targets of price manipulation. They should only be purchased with extreme caution.
A RS doesn't cause equity loss. The market cap will be the same regardless and will probably get a boost going on the Nasdaq. Why are people so sure any news "besides phase 3 success" will catapult the stock where it sustains a needed level? Also, a partnership deal might be reliant upon CTIX up-listing. Again, time will tell... If Leo is forced to do a RS at a much lower level, then he wasted all this time not being on the Nasdaq. Just my opinion and we will shortly see if P news keeps this above 3?
It's all perception... I'll gladly give up 75 percent of my shares, not lose any equity and move off the pinks... Now, some will say a RS announcement will cause the PPS to drop. Well, the PPS just dropped 10 percent on B news... Remember, they're not doing a RS because their being de-listed a big difference. Again, we will see if Leo can get the PPS higher? So far this year he's been unsuccessful. Down now 38 percent YTD... Also, would a partnership deal warrant CTIX being off-the-pinks?
2.94, Maybe Leo will wake up and get a partnership or do a RS? This market (pinks) will not allow CTIX to gain attention from the real investment world. Down 10 percent on the B news...
All those positive posts this year and the stock is down 35 percent. Jeez, something is clearly wrong. Maybe, the CEO needs to find a partner or do a RS? Dilution has not been the issue here and I highly doubt the "negative posts" are driving all those newbies to sell or not invest. Again, negativity is fed by PPS performance, always has been and always will. The positive posts here out-number the negative ones. Can't blame IHUB for PPS failure, it's more the market they trade on.
You missed the point on my original post. The PPS is down 35 percent YTD with plenty of good news. Meaning, what will it take to move the PPS higher (above 4) so they can up-list? Last week's rally is another example of how easily the PPS is manipulated on the pinks. This is not being negative, the benefits of up-listing is obvious.